Trando, A.; Ghamsari, F.; Yeung, P.; Costello, C.; Saunders, I.; Jeong, A.-R.
Outcomes of Idecabtagene Vicleucel Therapy in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience. Biomedicines 2025, 13, 36.
https://doi.org/10.3390/biomedicines13010036
AMA Style
Trando A, Ghamsari F, Yeung P, Costello C, Saunders I, Jeong A-R.
Outcomes of Idecabtagene Vicleucel Therapy in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience. Biomedicines. 2025; 13(1):36.
https://doi.org/10.3390/biomedicines13010036
Chicago/Turabian Style
Trando, Aaron, Farid Ghamsari, Philip Yeung, Caitlin Costello, Ila Saunders, and Ah-Reum Jeong.
2025. "Outcomes of Idecabtagene Vicleucel Therapy in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience" Biomedicines 13, no. 1: 36.
https://doi.org/10.3390/biomedicines13010036
APA Style
Trando, A., Ghamsari, F., Yeung, P., Costello, C., Saunders, I., & Jeong, A.-R.
(2025). Outcomes of Idecabtagene Vicleucel Therapy in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience. Biomedicines, 13(1), 36.
https://doi.org/10.3390/biomedicines13010036
